Company page

Cansino Biologics, Inc. Class A

Cansino Biologics, Inc. Class A is a public company listed on the 6ix platform under the ticker 688185. Based in China, the company has a market capitalization of approximately 1.41 billion USD. Cansino focuses on developing innovative biopharmaceutical products, particularly in the field of vaccines.